StockRadar

The Scoreboard

Every "good news / bad news" call we make goes on this page — including the ones that miss. Reviewed weekly, never deleted, never cherry-picked. This page exists because we think the industry's habit of advertising two winners from 2023 and hiding everything else is a scam-shaped habit.

6calls made (since Oct 8, 2026)
0 / 6reviewed so far
—accuracy (first review: Oct 16)

How we score ourselves

  • What counts as a call: any item in the Daily Radar labeled "good for X" or "bad for X" with a named ticker.
  • Review window: the 5 trading days after publication. Direction of the call vs. the stock's move relative to the S&P 500.
  • Judged by: "Correct", "Wrong", or "Too close to call" — the last one counts against us in the headline accuracy number.
  • What we never do: delete calls, move goalposts after the fact, or advertise individual winners without the full list.
  • What this is not: a promise of future accuracy, or investment advice. It's accountability.

    • Call log

    DateCallLabel5-day outcome
    Oct 8Fed minutes hint another hike — pressure on growth stocksBAD · market-wideReviews Oct 15
    Oct 830-yr yield at 24-yr high — headwind for NVDA/TSLA-type namesBAD · growthReviews Oct 15
    Oct 8Oil > $100 — helps energy, hurts airlines/consumerMIXEDReviews Oct 15
    Oct 8Chip selloff was macro, not company news — no thesis change for NVDANEUTRAL-HOLD · NVDAReviews Oct 15
    Oct 8SpaceX $40B raise (FT) — demand signal for NVIDIAGOOD · NVDAReviews Oct 15
    Oct 8Anthropic Haiku 5.5 — falling AI costs widen the marketGOOD · AI softwareReviews Oct 15

    Why we're confident enough to publish this

    Most services sell certainty. We sell a batting average. If our 4-week rolling accuracy falls below 60%, paying subscribers get that month free — automatically, no support ticket required. We'd rather refund you than become the kind of service that hopes you don't check.

    Not investment advice. Past accuracy does not guarantee future results. TickerWhy is a general-circulation publication; our team holds no positions in covered securities.
    ← Back to TickerWhy